About us
Molecular Diagnostics for All
Pathgen Diagnostik Teknologi, established in 2020, is focused on advancing health equity in precision medicine by providing affordable molecular diagnostics for oncology and non-communicable diseases. The company uses advanced genetic technology to address the genomic gaps in the Global South. Employing techniques like multiomics analysis, CRISPR, and digital pathology, PathGen aims to drive innovation and transform Indonesia’s healthcare sector.
Vision
“Democratizing genomics solutions in lower & middle – income countries”
Mission
“Providing low-cost molecular diagnostics for cancer and other diseases in Indonesia and engaging in capacity building through knowledge exchange with the global partners.”